Literature DB >> 11773458

The epidemiology of end-stage renal disease in Iran in an international perspective.

Ali Nobakht Haghighi1, Behrooz Broumand, Marco D'Amico, Francesco Locatelli, Eberhard Ritz.   

Abstract

INTRODUCTION: The epidemiology of end-stage renal disease (ESRD) and renal replacement therapy (RRT) is under continuous evolution all over the world. We report here the epidemiological analysis of ESRD and RRT in Iran and discuss it against the background of the international situation.
METHODS: This epidemiological report is based on data from centre questionnaires which were collected in Iran from 1997 onwards, with a response rate of 100%.
RESULTS: The prevalence/incidence of RRT patients were 238/49.9 p.m.p. in the year 2000. Haemodialysis and kidney transplantation were the most common RRT modalities, accounting for 53.7% and 45.5% of prevalent RRT patients, respectively. The proportion treated by peritoneal dialysis was very low (<1%). Home haemodialysis was not performed. The majority of haemodialysis centres used synthetic membranes (70%) and 100% of the sessions were performed using acetate as a buffer; 42.5% of haemodialysis patients were treated with a twice-weekly regimen, whilst 49.6% were on the standard thrice-weekly regimen. The majority of RRT patients in Iran were young to middle aged. The great majority of renal allografts came from living donors (mainly unrelated to recipients). The main renal diseases leading to ESRD were diabetes and hypertension. The third most common category was "cause unknown".
CONCLUSION: The epidemiology of RRT in Iran is characterized by: (i) young patient age (younger than the international average); (ii) high proportion of patients receiving renal allograft; (iii) use of living-unrelated donors as the major source of renal allografts.

Entities:  

Mesh:

Year:  2002        PMID: 11773458     DOI: 10.1093/ndt/17.1.28

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  13 in total

Review 1.  Infrequent dialysis: a new paradigm for hemodialysis initiation.

Authors:  Connie M Rhee; Mark Unruh; Jing Chen; Csaba P Kovesdy; Phillip Zager; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2013-09-09       Impact factor: 3.455

2.  Correlation of anti-heat shock protein 70 antibodies serum level with malnutrition-inflammation score in hemodialysis patients.

Authors:  Neda Haghighat
Journal:  Int Urol Nephrol       Date:  2019-09-04       Impact factor: 2.370

3.  Graft survival rate of renal transplantation: a single center experience, (1999-2009).

Authors:  A Almasi-Hashiani; A R Rajaeefard; J Hassanzade; H Salahi; S Nikeghbalian; P Janghorban; S A Malek-Hosseini
Journal:  Iran Red Crescent Med J       Date:  2011-06-01       Impact factor: 0.611

4.  The role of diabetes mellitus and hypertension in chronic kidney disease.

Authors:  Seyed Bahman Ghaderian; Seyed Seifollah Beladi-Mousavi
Journal:  J Renal Inj Prev       Date:  2014-12-01

5.  Outcome of patients on haemodialysis in Khuzestan, Iran.

Authors:  Seyed Seifollah Beladi Mousavi; Mohammad Javad Alemzadeh Ansari; Bahman Cheraghian
Journal:  NDT Plus       Date:  2011-04

6.  Administration of pentoxifylline to improve anemia of hemodialysis patients.

Authors:  Heshmatolah Shahbazian; Ali Ghorbani; Azita Zafar-Mohtashami; Abdolreza Balali; Armaghan AleAli; Gholam Reza Lashkarara
Journal:  J Renal Inj Prev       Date:  2016-11-26

7.  Upper extremity axillary loop grafts: an opportunity in hemodialysis access.

Authors:  Jalaladin Khoshnevis; Mohammad Reza Sobhiyeh; Saran Lotfolahzadah; Fatemah Hoseinzadegan Shirazi; Amir Hosein Jalali
Journal:  Nephrourol Mon       Date:  2012-12-15

8.  Comparative study on the National Renal Disease Registry in America, England and Iran.

Authors:  Sima Ajami; Mahdi Askarianzadeh; Sakineh Saghaeiannejad-Isfahani; Mojgan Mortazavi; Asghar Ehteshami
Journal:  J Educ Health Promot       Date:  2014-06-23

9.  Chronic graft loss and death in patients with post-transplant malignancy in living kidney transplantation: a competing risk analysis.

Authors:  Mahmoud Salesi; Zohreh Rostami; Abbas Rahimi Foroushani; Ali Reza Mehrazmay; Jamile Mohammadi; Behzad Einollahi; Saeed Asgharian; Mohammad Reza Eshraghian
Journal:  Nephrourol Mon       Date:  2014-03-10

10.  Competing Risk Analyses of Patients with End-Stage Renal Disease.

Authors:  Reza Tabrizi; Mahmood Moosazadeh; Eghbal Sekhavati; Maryam Jalali; Mahdi Afshari; Maryam Akbari; Mohammad Reza Baneshi
Journal:  Electron Physician       Date:  2015-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.